ANALISIS MINIMALISASI BIAYA PENGOBATAN AMLODIPIN DAN KANDESARTAN PADA PASIEN RAWAT JALAN PENDERITA HIPERTENSI DI RSPAD GATOT SOEBROTO TAHUN 2023

Shinta Nabila Yudhanti, . (2024) ANALISIS MINIMALISASI BIAYA PENGOBATAN AMLODIPIN DAN KANDESARTAN PADA PASIEN RAWAT JALAN PENDERITA HIPERTENSI DI RSPAD GATOT SOEBROTO TAHUN 2023. Skripsi thesis, Universitas Pembangunan Nasional Veteran Jakarta.

[img] Text
Abstrak.pdf
Download (139kB)
[img] Text
Awal.pdf
Download (905kB)
[img] Text
Bab 1.pdf
Restricted to Repository UPNVJ Only
Download (88kB)
[img] Text
Bab 2.pdf
Restricted to Repository UPNVJ Only
Download (299kB)
[img] Text
Bab 3.pdf
Restricted to Repository UPNVJ Only
Download (152kB)
[img] Text
Bab 4.pdf
Restricted to Repository UPNVJ Only
Download (125kB)
[img] Text
Bab 5.pdf
Restricted to Repository UPNVJ Only
Download (76kB)
[img] Text
Daftar Pustaka.pdf
Download (181kB)
[img] Text
Riwayat Hidup.pdf
Restricted to Repository UPNVJ Only
Download (85kB)
[img] Text
Lampiran.pdf
Restricted to Repository UPNVJ Only
Download (1MB)
[img] Text
Plagiarisme.pdf
Restricted to Repository staff only
Download (8MB)
[img] Text
Jurnal Repository UPNVJ.pdf
Restricted to Repository staff only
Download (293kB)

Abstract

Indonesians suffer from a high prevalence of cardiovascular disorders, including hypertension. The prolonged duration of hypertension treatment and its high costs are related to the patient’s economic status. In the treatment of stage one hypertension, there are several alternatives therapeutic options. Various alternative drugs in antihypertensive will cause differences in cost. Pharmacoeconomic studies are needed due to the differences in antihypertensive costs. Finding the lowest possible price for treating hypertensive outpatients at Gatot Soebroto Army Hospital with amlodipine and kandesartan was the goal of this cost minimization study. Secondary data provides information that is used in observational research., such as patient billing information and medical records. The study was conducted on 72 patients. Antihypertensive drug costs, doctor’s fees, and supporting cost were the cost components studied. The result of the study showed that there was a significant difference in total direct medical cost for amlodipine and candesartan monotherapy (p value≤0,001). The average total direct medical costs of amlodipine treatment is lower which about Rp347.706,- while candesartan is Rp365.450,-. Amlodipine monotherapy treatment is more cost minimize compared to candesartan.

Item Type: Thesis (Skripsi)
Additional Information: [No.Panggil: 2010212042] [Pembimbing 1: Primayanti Nurul Ilmi] [Pembimbing 2: Erna Harfiani] [Penguji : Dhigna Luthfiyani C. P.]
Uncontrolled Keywords: Cost Minimization Analysis, Pharmacoeconomic, Hypertension, Amlodipine, Candesartan
Subjects: R Medicine > RA Public aspects of medicine
R Medicine > RM Therapeutics. Pharmacology
R Medicine > RS Pharmacy and materia medica
Divisions: Fakultas Kedokteran > Program Studi Farmasi (S1)
Depositing User: SHINTA NABILA YUDHANTI
Date Deposited: 06 Sep 2024 03:15
Last Modified: 06 Sep 2024 03:15
URI: http://repository.upnvj.ac.id/id/eprint/31809

Actions (login required)

View Item View Item